Price of COVID-19 treatment Azvudine cut
The price of domestically developed COVID-19 treatment Azvudine, has been cut to 11.58 yuan ($1.75) per tablet, so as to be included in China's updated medical reimbursement list from March, the National Healthcare Security Administration said on Wednesday.
The listing price of the oral treatment online ranges from 270 to 330 yuan per bottle in different regions, according to public information.
The updated list will take effect from March 1. Currently, all COVID-19 treatments are temporarily covered by the country's medical insurance program.
Huang Xinyu, an official with the administration, said during an interview with China Central Television that the price cut is large, and has met expectations of medical insurance authorities, reflected the sincerity of the drug developer and will benefit patients.
- Crabapple flowers and cherry blossoms create springtime splendor in Yunnan
- New 'air taxis' debut in Central China as nation accelerates low-altitude drive
- TüV Rheinland invests $21.74 million in Guangzhou operation center
- Chinese courts crack down on telecom fraud linked to northern Myanmar
- Chinese courts conclude trials of two criminal gangs from northern Myanmar
- Guarding Great Wall as lifelong commitment for Beijing local villager
